Dr. Andrea Cercek
Medical Oncologist
- 1275 York Avenue, New York, NY 10065
Dr. Andrea Cercek is a leading medical oncologist at MSKCC, recognized for her expertise in immunotherapy for colorectal cancer. She graduated from Washington University School of Medicine and completed her residency at Johns Hopkins Hospital. Dr. Cercek is board-certified in Medical Oncology and is a member of ASCO and the Society for Immunotherapy of Cancer (SITC). With over 130 publications, her research has been instrumental in advancing immunotherapeutic strategies, earning her accolades such as the ASCO Young Investigator Award.
Education
- Medical School: Washington University School of Medicine
- Residency: Johns Hopkins Hospital
- Board Certification: Medical Oncology
Professional Memberships and Affiliation
- American Society of Clinical Oncology (ASCO)
- Society for Immunotherapy of Cancer (SITC)
- American Gastroenterological Association (AGA)
Clinical Experience
Dr. Andrea Cercek has amassed over 15 years of clinical experience in medical oncology, specializing in colorectal cancer at Memorial Sloan Kettering Cancer Center (MSKCC). She is actively involved in cutting-edge immunotherapy research, particularly focusing on mismatch repair-deficient colorectal cancers. Her clinical practice involves leading groundbreaking clinical trials, developing personalized treatment plans, and collaborating with multidisciplinary teams to enhance patient outcomes.
Research and Publications
- “Immunotherapy for Mismatch Repair-Deficient Colorectal Cancer” New England Journal of Medicine
- “Clinical Trials in Immunotherapy for Colorectal Cancer” Journal of Immunotherapy
- “Advancements in Immunotherapy for Gastrointestinal Cancers” Cancer Immunology Research
Dr. Andrea Cercek is a leading medical oncologist at MSKCC, recognized for her expertise in immunotherapy for colorectal cancer. She graduated from Washington University School of Medicine and completed her residency at Johns Hopkins Hospital. Dr. Cercek is board-certified in Medical Oncology and is a member of ASCO and the Society for Immunotherapy of Cancer (SITC). With over 130 publications, her research has been instrumental in advancing immunotherapeutic strategies, earning her accolades such as the ASCO Young Investigator Award.